CRP and myocardial ischemia: Second, we were able to investigate a range of systemic inflammation biomarkers, including CRP and differential leukocyte count, and composite measures such as LMR, NLR, PLR, and SII, as well as a range of outcomes: incident CVD and its main subtypes, including IHD, stroke and heart failure.